Tecogen Inc. TGEN
3.05
0.03
0.99%
as of 25 Sep
- Market cap
- $91.2M
- P/E
- 0.0×
Follow TGEN
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
9.12 | 4.97 | 2.93 | 6.37 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(71.30) | (52.24) | (24.59) | (66.54) | |
P/B ratio |
10.03 | 6.27 | 3.91 | 8.92 | |
Price to Tangible BV |
12.24 | 7.44 | 4.71 | 10.92 | |
EV/Sales |
8.66 | 4.60 | 2.67 | 6.20 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(76.33) | (12.58) | (5.89) | (13.14) | |
EV/FCF |
(65.89) | (12.06) | (5.72) | (12.85) | |
Quick Ratio |
1.83 | 1.82 | 1.65 | 1.35 | |
Current Ratio |
2.71 | 3.12 | 3.02 | 2.93 | |
Net Debt/EBITDA |
7.66 | 4.13 | 4.42 | 3.10 | |
Debt/Assets |
2.25% | 2.68% | 3.15% | 3.13% | |
Debt/Equity |
0.04 | 0.05 | 0.06 | 0.06 | |
Asset Turnover |
0.81 | 0.80 | 0.81 | 0.82 | |
Operating CF/Net income |
1.67 | 0.64 | 1.47 | 1.10 | |
Capex/Depreciation |
(0.32) | (0.03) | (0.17) | (0.25) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
4.15% | 5.78% | 5.74% | 5.57% | |
Selling, General and Administrative Expense of Revenue |
55.47% | 87.93% | 68.81% | 69.63% | |
Intangible Assets out of Total Assets |
0.11 | 0.09 | 0.10 | 0.10 | |
Share Based Compensation of Revenue |
1.76% | 2.60% | 2.08% | 2.54% | |
Graham Net Nets |
0.06 | 0.10 | 0.15 | 0.06 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.38%) | (5.87%) | (12.89%) | (6.51%) | |
Free Cash Flow Yield |
(1.44%) | (7.68%) | (15.94%) | (7.57%) | |
Revenue per Share |
0.25 | 0.20 | 0.21 | 0.19 | |
Operating CF per Share |
(0.12) | (0.09) | (0.10) | (0.08) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.13) | (0.10) | (0.11) | (0.08) | |
Cash per Share |
0.53 | 0.46 | 0.31 | 0.23 | |
Shareholders Equity per Share |
0.88 | 0.79 | 0.65 | 0.59 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.88 | 0.79 | 0.65 | 0.59 | |
Free Cash Flow |
(3.64) | (2.62) | (3.15) | (2.42) | |
Working Capital |
20.26 | 19.62 | 17.75 | 15.81 | |
Capital Expenditures |
(0.07) | (0.04) | (0.05) | (0.07) | |
Net Current Asset Value |
15.93 | 13.37 | 11.62 | 9.97 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(29.67%) | (75.10%) | (33.47%) | (37.39%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
6.47 | 5.42 | 5.59 | 5.55 | |
Average Payables |
4.13 | 3.76 | 3.98 | 4.01 | |
Average Inventory |
9.73 | 10.29 | 10.66 | 10.85 | |
Average Assets |
34.47 | 34.04 | 32.10 | 29.98 | |
Average Common Equity |
18.26 | 15.80 | 14.53 | 13.25 |
Columns are period end dates